menu
    • menu

    Company profile for Latigo Biotherapeutics

    NEW Drugs in Dev: 5
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Latigo Biotherapeutics is a clinical-stage enterprise dedicated to pioneering innovative non-opioid pain medications distinguished by their best-in-class profiles. Our efforts at Latigo are grounded in proprietary in-house research and unique insights. Beginning with advanced models, human biological understanding, and a distinctive discovery engine, we stand out, providing unparalleled potential for best-in-class solutions. W...
    Latigo Biotherapeutics is a clinical-stage enterprise dedicated to pioneering innovative non-opioid pain medications distinguished by their best-in-class profiles. Our efforts at Latigo are grounded in proprietary in-house research and unique insights. Beginning with advanced models, human biological understanding, and a distinctive discovery engine, we stand out, providing unparalleled potential for best-in-class solutions. With several groundbreaking pain programs currently in the discovery and development stages, we leverage our internal ion channel expertise to offer exceptional best-in-class possibilities.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Latigo BiotherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Thousand Oaks, CA 91320
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://latigobio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bonstein Joins Latigo Board as Audit Committee Chair
    Bonstein Joins Latigo Board as Audit Committee Chair

    08 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-08/latigo-biotherapeutics-appoints-sara-m-bonstein-to-its-board-of-directors-and-as-audit-committee-ch

    PHARMIWEB
    08 Apr 2026
    Share Share
    Latigo Bio Appoints Neha Krishnamohan As Cfo & Cbo
    Latigo Bio Appoints Neha Krishnamohan As Cfo & Cbo

    03 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260303682310/en/Latigo-Biotherapeutics-Appoints-Neha-Krishnamohan-as-Chief-Financial-Officer-and-Chief-Business-Officer

    BUSINESSWIRE
    03 Mar 2026
    Share Share
    Latigo Bio Closes $150M Series B to Advance Pain Therapeutics
    Latigo Bio Closes $150M Series B to Advance Pain Therapeutics

    17 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/latigo-biotherapeutics-closes-150-million-in-series-b-financing-to-advance-non-opioid-pain-therapeutics-302397457.html

    PR NEWSWIRE
    17 Mar 2025
    Share Share
    Latigo Bio Granted FDA Fast Track Designation for LTG-001
    Latigo Bio Granted FDA Fast Track Designation for LTG-001

    03 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/latigo-biotherapeutics-granted-fda-fast-track-designation-for-ltg-001--potential-best-in-class-nav1-8-inhibitor-for-the-non-opioid-treatment-of-acute-pain-302387994.html

    PR NEWSWIRE
    03 Mar 2025
    Share Share
    Latigo Biotherapeutics Appoints Timothy P. Walbert as Board Chair
    Latigo Biotherapeutics Appoints Timothy P. Walbert as Board Chair

    19 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/latigo-biotherapeutics-appoints-industry-veteran-timothy-p-walbert-as-board-chair-302309161.html

    PR NEWSWIRE
    19 Nov 2024
    Share Share
    Pain medicine biotech Latigo taps CRO founder for CMO role
    Pain medicine biotech Latigo taps CRO founder for CMO role

    20 Aug 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/cro/pain-medicine-biotech-latigo-taps-cro-founder-cmo-role

    FIERCE BIOTECH
    20 Aug 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search